Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions

American Journal of Surgical Pathology

Volumn 33, Issue 6, 2009, Pages 874-885

  Tátrai, Péter ^a   Somorácz, Áron ^a   Batmunkh, Enkhjargal ^a   Schirmacher, Peter ^b   Kiss, András ^a   Schaff, Zsuzsa ^a   Nagy, Péter ^a   Kovalszky, Ilona ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Agrin; Differential diagnosis; Dysplastic nodule; Hepatocellular adenoma; Hepatocellular carcinoma

Indexed keywords

AGRIN; CD34 ANTIGEN; CYTOKERATIN 7; GLYPICAN 3; TUMOR MARKER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLOOD VESSEL; CANCER GRADING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NODULAR HYPERPLASIA; TUMOR DIFFERENTIATION; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADENOMA, LIVER CELL; ADULT; AGED; AGRIN; ANTIGENS, CD34; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 67549119075     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318194b3ea     Document Type: Article

References (25)

1. Batmunkh E, Tátrai P, Szabó E, et al. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Hum Pathol. 2007;38:1508-1515.
2. Baumhoer D, Tornillo L, Stadlmann S, et al. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am J Clin Pathol. 2008;129:899-906.
3. Bioulac-Sage P, Balabaud C, Bedossa P, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol. 2007;46:521-527.
4. Capurro M, Wanless IR, Sherman M, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003;125:89-97.
5. Coston WM, Loera S, Lau SK, et al. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry. Am J Surg Pathol. 2008;32:433-444.
6. Crosby HA, Nijjar SS, de Goyet Jde V, et al. Progenitor cells of the biliary epithelial cell lineage. Semin Cell Dev Biol. 2002;13:397-403.
7. Di Tommaso L, Franchi G, Park YN, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology. 2007;45:725-734.
8. Falkowski O, An HJ, Ianus IA, et al. Regeneration of hepatocyte "buds" in cirrhosis from intrabiliary stem cells. J Hepatol. 2003;39: 357-364.
9. Fischer HP, Zhou H. Nodular lesions of liver parenchyma caused by pathological vascularisation/perfusion. Pathologe. 2006;27:273-283.
10. Forner A, Hessheimer AJ, Isabel Real M, et al. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2006;60:89-98.
11. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis. 2005;25:133-142.
12. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002;13:389-396.
13. Libbrecht L, Severi T, Cassiman D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol. 2006;30:1405-1411.
14. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178:493-497.
15. Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22:656-662.
16. Park YN, Kojiro M, Di Tommaso L, et al. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer. 2007;109:915-923.
17. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular patho-genesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163-170.
18. Roncalli M, Roz E, Coggi G, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology. 1999;30: 1174-1178.
19. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25:3818-3822.
20. Sell S. The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol. 1993;37:189-201.
21. Tátrai P, Dudás J, Batmunkh E, et al. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab Invest. 2006;86:1149-1160.
22. Theuerkauf I, Zhou H, Fischer HP. Immunohistochemical patterns of human liver sinusoids under different conditions of pathologic perfusion. Virchows Arch. 2001;438:498-504.
23. Wang XY, Degos F, Dubois S, et al. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol. 2006;37:1435-1441.
24. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol. 2006;12:1175-1181.
25. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515-524.